Publications — Group B streptococcus
Return to Publications Menu
2006 to present:
Centers for Disease Control and Prevention. Perinatal Group B Streptococcal Disease After Universal Screening Recommendations --- United States, 2003-2005. Morb Mortal Wkly Rep 2007;56(28):701-5.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2006. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gbs06.pdf
Schrag SJ, Hadler J, Arnold KE, et al. Risk factors for invasive perinatal Escherichia coli sepsis in the era of widespread intrapartum antibiotic use. Pediatrics 2006;118(2):570-6.
Schrag SJ, Stoll BJ. Early-onset neonatal sepsis in the era of wide-spread intrapartum chemoprophylaxis. Ped Infect Dis J 2006;25(10):939-40.
Back to Top
2000-2005:
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2005. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gbs05.pdf
Centers for Disease Control and Prevention. Early-Onset and Late-Onset Neonatal Group B Streptococcal Disease – United States, 1996-2004. MMWR Morb Mortal Wkly Rep 2005;54(47):1205-8.
Eisenberg E, Craig AS, Gautam S et al. Prevention Strategies for Perinatal Group B Streptococcal Disease: Beyond Screening. Ped Infect Dis J 2005;24:520-4.
Law, MR , Palomaki, G , Alfirevic, Z, Gilbert, R, Heath, P, McCartney, C, Reid, T and Schrag, S. The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society. J Med Screen 2005;12:60-8.
Morin CA, White K, Schuchat A, Danila RN, Lynfield R. Perinatal group B streptococcal disease prevention, Minnesota. Emerg Infect Dis 2005;11(9):1467-9.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2004. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gbs04.pdf
Centers for Disease Control and Prevention. Diminishing Racial Disparities in Early-Onset Neonatal Group B Streptococcal Disease, United States, 2000 - 2003. MMWR Morb Mortal Wkly Rep 2004; 53 (No.RR-23): 502-5.
Centers for Disease Control and Prevention. Laboratory Practices for Prenatal Group B Streptococcal Disease. MMWR Morb Mortal Wkly Rep 2004; 53 (No.RR-23): 506-9.
Balter S, Zell ER, O’Brien K, Roome A, Noga H, Thayu M, Schuchat A. Impact of intrapartum antibiotics on the care and evaluation of the newborn. Pediatr Infect Dis 2003;22:853-7.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2003. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gbs03.pdf
Moore MR. Schrag SJ. Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 2003;3(4):201-13.
Schrag SJ, Arnold KE, Mohle-Boetani JC, Lynfield R, Zell ER, Stefonek K, Noga H, Craig AS, Sanza LT, Smith G, Schuchat A. Prenatal Screening for Infectious Diseases and Opportunities for Prevention. Obstet Gynecol 2003;102:753-60.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2002. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gbs02.pdf
Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease. MMWR Morb Mortal Wkly Rep 2002;51(No.RR-11):1-22.
Hyde TB, Hilger TM, Reingold A, Farley MM, O’Brien KL, and Schuchat A for the Active Bacterial Core surveillance (ABCs) of the Emerging Infections Program Network. Trends in the incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics 2002;110(4):690-5.
Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig A, Harrison LH, Reingold A, Stefonek K, Smith G, Gamble M, Schuchat A. A population-based comparison of strategies to prevent early onset group Bstreptococcal disease in neonates. New Engl J Med 2002;347:233-9.
Schuchat A, Roome A, Zell ER, Linardos H, Zywicki S, O’Brien KL. Integrated monitoring of a new group B streptococcal disease prevention program and other perinatal infections. Maternal Child Health J 2002;6(2):107-14.
Baltimore RS, Huie SM, Meek JI, Schuchat A, O’Brien KL. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 2001;108(5):1094-8.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2001. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gbs01.pdf
Farley MM. Group B Streptococcal Infections in Nonpregnant Adults. Clin Infect Dis 2001;33:556-61. Henning KJ, Hall EL, Dwyer DM, Billmann L, Schuchat A, Johnson JA, Harrison LH. Invasive group B streptococcal disease in Maryland nursing home residents. J Infect Dis 2001;183:1138-42.
Schuchat A. Group B streptococcal infections: from trials and tribulations to triumph and trepidation. Clin Infect Dis 2001;33:751-6.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2000. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gbs00.pdf.
Centers for Disease Control and Prevention. Adoption of perinatal group B streptococcal disease prevention recommendations by prenatal-care providers- Connecticut and Minnesota. MMWR Morb Mortal Wkly Rep 2000; 49(11):228-32.
Centers for Disease Control and Prevention. Early-onset group B streptococcal disease, United States, 1998-1999. MMWR Morb Mortal Wkly Rep 2000;49(35):793-6.
Centers for Disease Control and Prevention. Hospital-based policies for prevention of perinatal group B streptococcal disease, United States 1999. MMWR Morb Mortal Wkly Rep 2000; 49(41):936-40.
Factor SH, Whitney CG, Zywicki SS, Schuchat A for the Active Bacterial Core Surveillance Team. Effects of hospital policies based on 1996 group B streptococcal disease consensus guidelines. Obstet Gynecol 2000;95:377-82.
Hager WD, Schuchat A, Gibbs R, Sweet R, Mead P, Larsen JW. Prevention of perinatal group B streptococcal infection: addressing current controversies. Obstet Gynecol 2000;96:141-5.
Schrag S, Whitney CG, Schuchat A. Neonatal group B streptococcal disease: How infection control teams can contribute to prevention efforts. Infect Control Hosp Epidemiol 2000:473-83.
Schrag SJ, Zywicki S, Farley M, Reingold A, Harrison L, Lefkowitz L, Hadler J, Danila R, Cieslak P, Schuchat A .. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15-20.
Schuchat A, Schrag S. Group B Streptococcus: from emerging infection to prevention success story. In: Scheld WM, Craig WA, Hughes JM. Emerging Infections 4. Washington, DC: American Society for Microbiology; 2000:107-20.
Back to Top
1995-1999:
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 1999. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gbs99.pdf
Centers for Disease Control and Prevention. Laboratory practices for prenatal group B streptococcal screening and reporting. MMWR Morb Mortal Wkly Rep 1999;48(20):426-8.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 1998. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gbs98.pdf
Centers for Disease Control and Prevention. Adoption of hospital policies for prevention of perinatal group B streptococcal disease – United States, 1997. MMWR Morb Mortal Wkly Rep 1998;47(32):665-70.
Harrison LH, Elliot JA, Libonati JP, Billmann L, Schuchat A, Dwyer DM, and the Maryland Bacterial Invasive Disease Surveillance Group. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. J Infect Dis 1998;177:998-1002.
Wessels MR, Kasper DL, Johnson KD, Harrison LH. Antibody responses in invasive group B streptococcal infection in adults. J Infect Dis 1998;178:569-72.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 1997. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gbs97.pdf
Centers for Disease Control and Prevention. Decreasing incidence of perinatal group B streptococcal disease -- United States, 1993-1995. MMWR Morb Mortal Wkly Rep 1997;46(21):473-7.
Rosenstein NE , Schuchat A, and the Neonatal Group B Streptococcal Disease Study Group. Opportunities for prevention of perinatal group B streptococcal disease: a multi-state surveillance analysis. Obstet Gynecol 1997;90:901-6.
Whitney C, Plikaytis BD, Gozansky W, Schuchat A, Neonatal group B streptococcal disease study group. Prevention practices for perinatal group B streptococcal disease: a multistate surveillance analysis. Obstet Gynecol 1997;89:28-32.
Blumberg HM, Stephens DS, Modansky M, Erwin M, Elliott J, Facklam RR, Schuchat A, Baughman W, Farley MM. Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis 1996;173:365-73.
Jackson L, Farley M, Schuchat A. Adult group B streptococcal disease. Ann Int Med 1996;125;152-3.
Schuchat A, Whitney C, Zangwill K. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Morb Mortal Wkly Rep 1996;45 (RR-7):1-24.
Farley MM. Group B Streptococcal Infection in Older Patients: Spectrum of Disease and Management Strategies. Drugs and Aging 1995;6:293-300.
Harrison LH, Ali A, Dwyer DM, et al. Relapsing invasive group B streptococcal infection in adults. Ann Intern Med 1995;123:421-7.
Jackson L, Hilsdon R, Farley M, Harrison L, Reingold A, Wenger JD, Schuchat A. Risk factors for group B streptococcal disease in adults. Ann Intern Med 1995;123:415-20.
Back to Top
1992 - 1994:
Schuchat A, Deaver-Robinson K, Plikaytis BD, Zangwill KM, Mohle-Boetani J, Wenger JD. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J 1994;13:623-9.
Farley MM, Harvey RC, Stull T, Smith JD, Schuchat A, Wenger JD, Stephens DS. A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults. N Engl J Med 1993;328:1807-11.
Mohle-Boetani JC, Schuchat A, Plikaytis BD, Smith JD, Broome CV. Comparison of prevention strategies for neonatal group B streptococcal infection: A population-based economic analysis. JAMA 1993;270:1442-8.
Zangwill KM, Schuchat A, Wenger JD, and the Group B Streptococcal Disease Study Group. Group B streptococcal disease in the United States: Report from a multistate active surveillance system. MMWR Morb Mortal Wkly Rep 1992; 41 [No. SS-6]:25-32.
Back to Top
|
